JUNTENDO UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- -
- Market Cap
- -
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
- First Posted Date
- 2022-05-26
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 524
- Registration Number
- NCT05392764
- Locations
- 🇯🇵
Mitsui Memorial Hospital, Chiyoda, Tokyo, Japan
🇯🇵International University of Health and Welfare Mita Hospital, Minato, Tokyo, Japan
🇯🇵Nishiarai Hospital, Adachi, Tokyo, Japan
Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations
Phase 2
Active, not recruiting
- Conditions
- EGFR Activating MutationNon-squamous Non-small-cell Lung Cancer
- Interventions
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 30
- Registration Number
- NCT05258279
- Locations
- 🇯🇵
Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
🇯🇵Saitama Cancer Center, Ina, Saitama, Japan
🇯🇵Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka, Japan
Induction of Transplant Tolerance in LDLT Via iTS
Phase 1
Active, not recruiting
- Conditions
- Living-donor Liver Transplantation
- Interventions
- Biological: JB-101
- First Posted Date
- 2021-07-06
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 10
- Registration Number
- NCT04950842
- Locations
- 🇯🇵
Juntendo University Hospital, Bunkyoku, Tokyo, Japan
🇯🇵Tokyo Women's Medical University Hospital, Shinjuku, Tokyo, Japan
🇯🇵Hiroshima University Hospital, Hiroshima, Japan
Correlation Between Cognitive Function and Relapse of Schizophrenia Regarding Dose Reduction
Not Applicable
Completed
- Conditions
- Schizophrenia Relapse
- Interventions
- Drug: reduction of risperidone, haloperidol, olanzapine, quetiapine, aripiprazole, paliperidone, levomepromazine, perphenazine
- First Posted Date
- 2017-01-13
- Last Posted Date
- 2021-09-09
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 139
- Registration Number
- NCT03019887
Comparison of Emergence and Oxygenation During One-lung Ventilation With Desflurane and Propofol Anesthesia
Not Applicable
Active, not recruiting
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 80
- Registration Number
- NCT02324283
- Locations
- 🇯🇵
University of Juntendo, Bunkyo-ku, Tokyko, Japan
Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy With Pitavastatin in Coronary Artery Disease (REAL-CAD)
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- First Posted Date
- 2010-01-06
- Last Posted Date
- 2021-05-17
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 13054
- Registration Number
- NCT01042730
- Locations
- 🇯🇵
Kyoto University Hospital, Kyoto, Japan
🇯🇵Juntendo University School of Medicine, Tokyo, Japan
Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)
Phase 4
Completed
- Conditions
- HypertensionCoronary Atherosclerosis
- Interventions
- First Posted Date
- 2006-02-22
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- Juntendo University
- Target Recruit Count
- 199
- Registration Number
- NCT00294567
- Locations
- 🇯🇵
Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
© Copyright 2025. All Rights Reserved by MedPath